rs10808555
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000501396.6(CASC8):n.546+23563C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.654 in 152,012 control chromosomes in the GnomAD database, including 32,685 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.65 ( 32685 hom., cov: 31)
Consequence
CASC8
ENST00000501396.6 intron
ENST00000501396.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.359
Publications
19 publications found
Genes affected
CASC8 (HGNC:45129): (cancer susceptibility 8)
POU5F1B (HGNC:9223): (POU class 5 homeobox 1B) This intronless gene was thought to be a transcribed pseudogene of POU class 5 homeobox 1, however, it has been reported that this gene can encode a functional protein. The encoded protein is nearly the same length as and highly similar to the POU class 5 homeobox 1 transcription factor, has been shown to be a weak transcriptional activator and may play a role in carcinogenesis and eye development. [provided by RefSeq, Apr 2009]
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.695 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CASC8 | NR_117100.1 | n.1176+23563C>T | intron_variant | Intron 5 of 5 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.654 AC: 99342AN: 151894Hom.: 32661 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
99342
AN:
151894
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.654 AC: 99413AN: 152012Hom.: 32685 Cov.: 31 AF XY: 0.657 AC XY: 48793AN XY: 74302 show subpopulations
GnomAD4 genome
AF:
AC:
99413
AN:
152012
Hom.:
Cov.:
31
AF XY:
AC XY:
48793
AN XY:
74302
show subpopulations
African (AFR)
AF:
AC:
24645
AN:
41438
American (AMR)
AF:
AC:
10790
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
2431
AN:
3468
East Asian (EAS)
AF:
AC:
3651
AN:
5160
South Asian (SAS)
AF:
AC:
3228
AN:
4816
European-Finnish (FIN)
AF:
AC:
7218
AN:
10570
Middle Eastern (MID)
AF:
AC:
216
AN:
294
European-Non Finnish (NFE)
AF:
AC:
45302
AN:
67972
Other (OTH)
AF:
AC:
1432
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1754
3508
5261
7015
8769
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2380
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.